stock · yahoo

Terumo Corporation

4543.T

$15.27
▲ 0.23 (1.5%)
polled

Below: live stock price for Terumo Corporation (4543.T), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.

Terumo Corporation (4543.T) is a Healthcare company based in Japan. Its primary business is Medical Devices. Over the past year 4543.T traded between 1,900 and 2,689 JPY. Trailing P/E sits near 21.57 on a market cap of about 3.55T JPY. It currently yields 1.50% in dividends.

Day
+1.50%
+0.23
Week
+0.23%
+0.03
Month
+2.25%
+0.34
Year
-3.49%
-0.55
Prev close
$15.04
Volume (24h)
$69.43M
Market cap
$22.52B
Currency
USD (native JPY)

Score

58/ 100 · Mixed

Coverage: 7/7
  • Value55
  • Quality59
  • Momentum30
  • Growth78
  • Risk71
  • Dividend56
  • Liquidity56

Composite of public market data. Informational only — not investment advice.

Trend projection

Where the recent trend points if it continues.

DowntrendFit 20%Pace -0.13% per bar
+5 bars+20 bars+60 bars+120 bars
+5 bars
15.1874
-0.52%
Bull16.664
Bear13.8416
+20 bars
15.0779
-1.24%
Bull18.1524
Bear12.5242
+60 bars
15.0358
-1.52%
Bull20.7355
Bear10.9028
+120 bars
15.0343
-1.53%
Bull23.6859
Bear9.5428

Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: 1σ ≈ ±2.1% per bar.

Interpretation

Composite signals look mixed. Strength: growth with weakness: momentum. Price sits in the middle of the recent range, trend is sloping downward.

Descriptive observation — not investment advice.

Score breakdown

Raw values behind each pillar so you can see what the composite is reading.

  • Value
    55/100

    Value looks mixed — driven by P/E (21.57).

    P/E:21.57P/B:2.13PEG:2.18
  • Quality
    59/100

    Quality looks mixed — driven by Gross margin (53.22%).

    ROE:10.85%ROA:6.92%Profit margin:13.90%Gross margin:53.22%
  • Momentum
    30/100

    Momentum looks weak — driven by 52w change (-4.39%).

    52w change:-4.39%
  • Growth
    78/100

    Growth looks strong — driven by Earnings growth (68.30%).

    Revenue growth:19.90%Earnings growth:68.30%
  • Risk
    71/100

    Risk looks solid — driven by Debt / equity (26.36).

    Beta:0.31Debt / equity:26.36
  • Dividend
    56/100

    Dividend looks mixed — driven by Payout ratio (26.91%).

    Dividend yield:1.50%Payout ratio:26.91%
  • Liquidity
    56/100

    Liquidity looks mixed — driven by Current ratio (2.19).

    Current ratio:2.19Quick ratio:1.31

Derived from public market data — informational, not investment advice.

Price report

How this asset has actually moved over the last 243 days.

Position in range64%
12.0639 low17.0736 high

Where the price sits between the window low and high.

Volatility (annualised)
33.9%

Spread of returns. Higher means larger swings in both directions.

Max drawdown
-25.0%

Worst peak-to-trough fall inside the window.

Below period high
-10.6%

Current price against the highest point in the window.

Best day
+18.57%
Worst day
-6.27%
Up days
51%

Share of days that closed above the one before.

Current streak
2 up
Typical day swing
2.4%

Average high-to-low spread within a single day.

Volume vs average
+16%

Last 10 days against the whole window.

Descriptive statistics over past prices — not a forecast and not investment advice.

Reference levels

Fibonacci retracements and extensions across the recent range.

60 bars

Reference only — not investment advice.

These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.

Next level above
15.5037 USD+1.55%
Fib 50% midpoint
Next level below
15.1332 USD-0.88%
Fib 61.8% retracement

Levels derived from: 17.0736 high → 13.9338 low · 60 bars

  • Resistance
    Fib +161.8% extension
    not reached
    22.1538 USD
    +45.11% from current
  • Resistance
    Fib +100% extension
    not reached
    20.2134 USD
    +32.40% from current
  • Resistance
    Fib +61.8% extension
    not reached
    19.014 USD
    +24.54% from current
  • Resistance
    Fib +27.2% extension
    not reached
    17.9277 USD
    +17.43% from current
  • Resistance
    Fib 23.6% retracement
    tested 10×
    16.3326 USD
    +6.98% from current
  • Resistance
    Fib 38.2% retracement
    tested 3×
    15.8742 USD
    +3.98% from current
  • Resistance
    Fib 50% midpoint
    tested 6×
    15.5037 USD
    +1.55% from current
  • Current
    15.2672 USD
  • Support
    Fib 61.8% retracementNearest
    tested 6×
    15.1332 USD
    -0.88% from current
  • Support
    Fib 78.6% retracement
    tested 19×
    14.6057 USD
    -4.33% from current
  • Support
    Fib −27.2% extension
    not reached
    13.0798 USD
    -14.33% from current
  • Support
    Fib −61.8% extension
    not reached
    11.9934 USD
    -21.44% from current
  • Support
    Fib −100% extension
    not reached
    10.794 USD
    -29.30% from current
How to read this

We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.

“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.

This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.

Financials

52w high
¥2,689
52w low
¥1,900
52w change
-4.39%
Day high
¥2,427.5
Day low
¥2,351
P/E (TTM)
21.57
Forward P/E
23.61
PEG
2.18
Price / Book
2.13
Beta (5Y)
0.31
Enterprise value
3.67T
EV / Revenue
3.1
EV / EBITDA
12.01
EPS (TTM)
¥111.49
Forward EPS
¥101.83
Dividend yield
1.50%
Dividend rate
¥36
Payout ratio
26.91%
Revenue (TTM)
1.18T
EBITDA
305.71B
Free cash flow
95.83B
Total cash
314.63B
Total debt
438.06B
Debt / Equity
26.36
Current ratio
2.19
Quick ratio
1.31
Profit margin
13.90%
Gross margin
53.22%
Return on assets
6.92%
Return on equity
10.85%
Shares outstanding
1.48B
Float
1.45B
Sector: HealthcareIndustry: Medical DevicesHQ: Japanwww.terumo.com

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular stent grafts, and others. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The Terumo Organ Technologies segment provides organ preservation devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Shibuya, Japan.

Analyst & Risk

Consensus

Analysts' consensus via Yahoo Finance — not investment advice.

Analysts: very positive
Mean rating1.50 / 5
Analysts13
Next earnings2026-11-12
Very positive: 3Positive: 9Neutral: 2
Analyst price target
¥3,012.31
Mean target · 13 analysts
+25.3%
mean target vs. price
Low ¥2,600Now ¥2,404.5High ¥3,400
Beta (vs S&P 500)
0.31
very stable
52-week change
-4.39%
Debt / Equity
26.36
very high leverage
Current ratio
2.19
Quick ratio
1.31
ROE
10.85%
ROA
6.92%
PEG ratio
2.18
EV / Revenue
3.1
EV / EBITDA
12.01
Revenue growth
19.90%
Earnings growth
68.30%
EBITDA
305.71B
Free cash flow
95.83B
Total cash
314.63B
Total debt
438.06B
Insider holdings
2.29%
Institutional
68.07%

Related

Other assets in this category.

Learn the terms

Live discussion

Sign in to join the discussion.

  • No comments yet. Be the first.